Literature DB >> 6989476

Extranodal non-Hodgkin's lymphoma presenting in the testicle: a clinical and pathologic study of 24 cases.

P R Duncan, F Checa, N F Gowing, T J McElwain, M J Peckham.   

Abstract

Twenty-four cases of extranodal non-Hodgkin's lymphoma presenting in the testicle are reviewed. All cases are diffuse lymphoma by the Rappaport classification. Cases clinically stages as I/II, (18/24) show a prolonged survival compared with those clinically staged as III/IV (6 of 24). Progressive involvement of either the lymphoid tissue in Waldeyer's ring or adjacent structures in the nasopharynx or oropharynx was noted in 22% (4 of 18) of Stage I/II cases. In 2 of the 24 (8%), there was asynchronous involvement of the opposite testicle. In patients with Stage I/II disease radiation therapy to the pelvic and paraaortic lymph nodes following inguinal orchidectomy is recommended. Systemic chemotherapy is recommended to follow radiation therapy unless bulky abdominal disease is present in which case it should precede radiation therapy. Prophylactic radiation of the opposite uninvolved testis is not recommended.

Entities:  

Mesh:

Year:  1980        PMID: 6989476     DOI: 10.1002/1097-0142(19800401)45:7<1578::aid-cncr2820450711>3.0.co;2-k

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

1.  Pathological stage ie lymphoma of the testis treated by local surgery alone.

Authors:  M W Kissin; A E Kark
Journal:  Postgrad Med J       Date:  1982-05       Impact factor: 2.401

2.  Testicular fluorine-18 fludeoxyglucose uptake on positron emission tomography CT in patients with lymphoma: clinical significance and management impact.

Authors:  P Sidhu; P Lin; H Son; D Rosenfeld; M Lin
Journal:  Br J Radiol       Date:  2014-10-21       Impact factor: 3.039

Review 3.  Lymphoma of the testis as primary location: tumour review.

Authors:  Georgios Koukourakis; Vassilios Kouloulias
Journal:  Clin Transl Oncol       Date:  2010-05       Impact factor: 3.405

4.  Lack of adhesion molecules in testicular diffuse centroblastic and immunoblastic B cell lymphomas as a contributory factor in malignant behaviour.

Authors:  W G Horstmann; W Timens
Journal:  Virchows Arch       Date:  1996-10       Impact factor: 4.064

5.  Rituximab plus a CHOP-like regimen, central nervous system prophylaxis, and contralateral testicular irradiation for localized primary testicular diffuse large B-cell lymphoma lead to prolonged progression-free survival.

Authors:  Kunimoto Ichikawa; Masaaki Noguchi; Michiaki Koike; Nanae Aritaka; Yasunobu Sekiguchi; Yoshitaka Sunami; Miyuki Tsutsui; Masaru Hosone; Takao Hirano; Akihiko Gotoh; Norio Komatsu
Journal:  Int J Hematol       Date:  2014-08-02       Impact factor: 2.490

6.  Primary testicular lymphoma.

Authors:  Filiz Vural; Seckin Cagirgan; Guray Saydam; Mine Hekimgil; Nur Akad Soyer; Murat Tombuloglu
Journal:  J Natl Med Assoc       Date:  2007-11       Impact factor: 1.798

7.  Involved field radiotherapy or chemotherapy in the management of stage I nodal intermediate grade non-Hodgkin's lymphoma.

Authors:  G M Jeffery; G M Mead; J M Whitehouse; R D Ryall
Journal:  Br J Cancer       Date:  1991-11       Impact factor: 7.640

8.  Prevalence And Clinical Significance Of Oncogenic CD79B And MYD88 Mutations In Primary Testicular Diffuse Large B-Cell Lymphoma: A Retrospective Study In China.

Authors:  Yan-Ping Chen; Long-Feng Ke; Jian-Ping Lu; Jian-Chao Wang; Wei-Feng Zhu; Fang-Fang Chen; Shao-Feng Lin; Chun-Wei Xu; Mei-Juan Wu; Gang Chen
Journal:  Onco Targets Ther       Date:  2019-11-26       Impact factor: 4.147

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.